MEDICREA: H1 2012 Sales
LYON, France--(BUSINESS WIRE)--Regulatory News:
The MEDICREA Group (FR0004178572-ALMED), listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its sales for the 1st half of 2012.